Learn all about the latest advances in IBD through a variety of scientific sessions at Digestive Disease Week® (DDW) 2017.
Our next advocate in our Digestive Disease Week® (DDW) patient advocate series is Megan Starshak, co-founder of The Great Bowel Movement.
Continuing an initiative that began last year, we are sharing stories from DDW patient advocates. Aaron Blocker, our first advocate to be featured this year, was diagnosed with Crohn’s Disease in 2009.
We kicked off DDW with more than 2,850 tweets on day 1 alone! Here are some of our favorites. Learn more about our Twitter presence: http://www.symplur.com/healthcare-hashtags/ddw16/
Genetic and ethnic factors may explain some of the observed differences in the incidence and treatment of inflammatory bowel disease (IBD), but socio-economic status also plays a role, according to Justin Sewell, MD, MPH, assistant professor of medicine at the University of California, San Francisco.
Inflammatory bowel disease (IBD) can be difficult to diagnose, monitor and manage. The Cochrane Collaboration can help gastroenterologists sort out the useful approaches from the dubious and potentially harmful.